spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Exploristics present the Welcome Organisation with Christmas Shoeboxes

Exploristics Ltd

The team at Exploristics present a Belfast homeless charity with Christmas shoeboxes, filled with basic essentials

The team at Exploristics have presented Belfast homeless charity, the Welcome Organisation, with Christmas shoeboxes for their homelessness appeal during, ‘Homelessness Awareness Week 2016’.

The Welcome Organisation, who provide potentially lifesaving services to some of the most vulnerable people living in Belfast, 365 days per year, were one of a number of local charities the Exploristics team chose to champion in 2016-17.

Kieran Hughes, Fundraising and Marketing Manager at the Welcome Organisation, called into the Exploristics office to talk to the team about the charity and how the shoeboxes will make a difference this Christmas.

The shoeboxes, filled with basic essentials, clothing, gift vouchers and food items will be donated to the homeless community in Belfast.

To find out more about the Welcome Organisation and what they do, visit their website here: http://www.homelessbelfast.org/ or, you can donate £3.00 by texting ‘WELC33 £3‘ to 70070.
phone +44 (0)28 9600 1996
email sales@exploristics.com
web www.exploristics.com
email Exploristics Ltd, Floor 4, 24 Linenhall Street, Belfast BT2 8BG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

November 16, 2017, Oxford, England and San Francisco, US. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast™ technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.
More info >>


White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>

Industry Events

Outsourcing in Clinical Trials Southeast 2018

13-14 March 2018, Durham, North Carolina

This year’s Outsourcing in Clinical Trials event builds on last year’s incredibly successful conference which will once again be returning to North Carolina with the aim of supporting trial sponsors and solution providers in the RTP and neighboring regions, ensuring trials are delivered on time and partnerships are bettered.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement